3.96 USD
▲-0.35+12.50%
2026-08-03
市值
$27.26M
市盈率
—
EPS
-2.62
股息率
—
52 周区间
2.90 – 23.43
成交量
138.70K
Beta
1.42
目标价
36.00
52W 低 2.9052W 高 23.43
价格走势
公司简介
Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company’s lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary li...